The global market for Quadrivalent Meningococcal Vaccine was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 272 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Quadrivalent Meningococcal Vaccine Market

The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.

Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Quadrivalent Meningococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Meningococcal Vaccine.

The Quadrivalent Meningococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quadrivalent Meningococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Quadrivalent Meningococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Quadrivalent Meningococcal Vaccine Market Report

Report Metric	Details
Report Name	Quadrivalent Meningococcal Vaccine Market
Accounted market size in year	US$ 183 million
Forecasted market size in 2031	US$ 272 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Polysaccharide Vaccine Conjugate Vaccine
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd., Zhejiang Tianyuan Biopharmaceutical Co., Ltd., Beijing Institute of Biological Products Co., Ltd., CanSino Biological Co., Ltd., Hualan Biological Vaccine Co., Ltd., Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quadrivalent Meningococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quadrivalent Meningococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Quadrivalent Meningococcal Vaccine Market growing?

Ans: The Quadrivalent Meningococcal Vaccine Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Quadrivalent Meningococcal Vaccine Market size in 2031?

Ans: The Quadrivalent Meningococcal Vaccine Market size in 2031 will be US$ 272 million.

Who are the main players in the Quadrivalent Meningococcal Vaccine Market report?

Ans: The main players in the Quadrivalent Meningococcal Vaccine Market are Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd., Zhejiang Tianyuan Biopharmaceutical Co., Ltd., Beijing Institute of Biological Products Co., Ltd., CanSino Biological Co., Ltd., Hualan Biological Vaccine Co., Ltd., Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

What are the Application segmentation covered in the Quadrivalent Meningococcal Vaccine Market report?

Ans: The Applications covered in the Quadrivalent Meningococcal Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Quadrivalent Meningococcal Vaccine Market report?

Ans: The Types covered in the Quadrivalent Meningococcal Vaccine Market report are Polysaccharide Vaccine, Conjugate Vaccine

1 Quadrivalent Meningococcal Vaccine Market Overview

1.1 Product Definition

1.2 Quadrivalent Meningococcal Vaccine by Type

1.2.1 Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Polysaccharide Vaccine

1.2.3 Conjugate Vaccine

1.3 Quadrivalent Meningococcal Vaccine by Application

1.3.1 Global Quadrivalent Meningococcal Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Quadrivalent Meningococcal Vaccine Market Size Estimates and Forecasts

1.4.1 Global Quadrivalent Meningococcal Vaccine Revenue 2020-2031

1.4.2 Global Quadrivalent Meningococcal Vaccine Sales 2020-2031

1.4.3 Global Quadrivalent Meningococcal Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Quadrivalent Meningococcal Vaccine Market Competition by Manufacturers

2.1 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Quadrivalent Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Date of Enter into This Industry

2.8 Global Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends

2.8.1 Global Quadrivalent Meningococcal Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue

2.8.3 Global Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Quadrivalent Meningococcal Vaccine Market Scenario by Region

3.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Quadrivalent Meningococcal Vaccine Sales by Region: 2020-2031

3.2.1 Global Quadrivalent Meningococcal Vaccine Sales by Region: 2020-2025

3.2.2 Global Quadrivalent Meningococcal Vaccine Sales by Region: 2026-2031

3.3 Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2020-2031

3.3.1 Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2020-2025

3.3.2 Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2026-2031

3.4 North America Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country

3.4.1 North America Quadrivalent Meningococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2031)

3.4.3 North America Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country

3.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Quadrivalent Meningococcal Vaccine Sales by Country (2020-2031)

3.5.3 Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Quadrivalent Meningococcal Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country

3.7.1 Latin America Quadrivalent Meningococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Quadrivalent Meningococcal Vaccine Sales by Type (2020-2031)

4.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Type (2020-2025)

4.1.2 Global Quadrivalent Meningococcal Vaccine Sales by Type (2026-2031)

4.1.3 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2020-2031)

4.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2020-2025)

4.2.2 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2026-2031)

4.2.3 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Quadrivalent Meningococcal Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Quadrivalent Meningococcal Vaccine Sales by Application (2020-2031)

5.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Application (2020-2025)

5.1.2 Global Quadrivalent Meningococcal Vaccine Sales by Application (2026-2031)

5.1.3 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2020-2031)

5.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2020-2025)

5.2.2 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2026-2031)

5.2.3 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Quadrivalent Meningococcal Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi-Pasteur

6.1.1 Sanofi-Pasteur Company Information

6.1.2 Sanofi-Pasteur Description and Business Overview

6.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolio

6.1.5 Sanofi-Pasteur Recent Developments/Updates

6.2 Walvax

6.2.1 Walvax Company Information

6.2.2 Walvax Description and Business Overview

6.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Walvax Quadrivalent Meningococcal Vaccine Product Portfolio

6.2.5 Walvax Recent Developments/Updates

6.3 Chengdu Kanghua Biological Products Co., Ltd.

6.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information

6.3.2 Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview

6.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates

6.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

6.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information

6.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview

6.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates

6.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

6.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information

6.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Description and Business Overview

6.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates

6.6 Beijing Institute of Biological Products Co., Ltd.

6.6.1 Beijing Institute of Biological Products Co., Ltd. Company Information

6.6.2 Beijing Institute of Biological Products Co., Ltd. Description and Business Overview

6.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates

6.7 CanSino Biological Co., Ltd.

6.7.1 CanSino Biological Co., Ltd. Company Information

6.7.2 CanSino Biological Co., Ltd. Description and Business Overview

6.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates

6.8 Hualan Biological Vaccine Co., Ltd.

6.8.1 Hualan Biological Vaccine Co., Ltd. Company Information

6.8.2 Hualan Biological Vaccine Co., Ltd. Description and Business Overview

6.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates

6.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

6.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information

6.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Description and Business Overview

6.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio

6.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis

7.2 Quadrivalent Meningococcal Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Quadrivalent Meningococcal Vaccine Production Mode & Process Analysis

7.4 Quadrivalent Meningococcal Vaccine Sales and Marketing

7.4.1 Quadrivalent Meningococcal Vaccine Sales Channels

7.4.2 Quadrivalent Meningococcal Vaccine Distributors

7.5 Quadrivalent Meningococcal Vaccine Customer Analysis

8 Quadrivalent Meningococcal Vaccine Market Dynamics

8.1 Quadrivalent Meningococcal Vaccine Industry Trends

8.2 Quadrivalent Meningococcal Vaccine Market Drivers

8.3 Quadrivalent Meningococcal Vaccine Market Challenges

8.4 Quadrivalent Meningococcal Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

Walvax

Chengdu Kanghua Biological Products Co.,Ltd.

Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

Beijing Institute of Biological Products Co., Ltd.

CanSino Biological Co., Ltd.

Hualan Biological Vaccine Co., Ltd.

Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

List of Tables

Table 1. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Quadrivalent Meningococcal Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Quadrivalent Meningococcal Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Quadrivalent Meningococcal Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Quadrivalent Meningococcal Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Quadrivalent Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Quadrivalent Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Quadrivalent Meningococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Quadrivalent Meningococcal Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Quadrivalent Meningococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Quadrivalent Meningococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Quadrivalent Meningococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Quadrivalent Meningococcal Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Quadrivalent Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Quadrivalent Meningococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Sanofi-Pasteur Company Information

Table 71. Sanofi-Pasteur Description and Business Overview

Table 72. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product

Table 74. Sanofi-Pasteur Recent Developments/Updates

Table 75. Walvax Company Information

Table 76. Walvax Description and Business Overview

Table 77. Walvax Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Walvax Quadrivalent Meningococcal Vaccine Product

Table 79. Walvax Recent Developments/Updates

Table 80. Chengdu Kanghua Biological Products Co., Ltd. Company Information

Table 81. Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview

Table 82. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 84. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates

Table 85. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information

Table 86. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview

Table 87. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 89. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates

Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information

Table 91. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Description and Business Overview

Table 92. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 94. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates

Table 95. Beijing Institute of Biological Products Co., Ltd. Company Information

Table 96. Beijing Institute of Biological Products Co., Ltd. Description and Business Overview

Table 97. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 99. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates

Table 100. CanSino Biological Co., Ltd. Company Information

Table 101. CanSino Biological Co., Ltd. Description and Business Overview

Table 102. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 104. CanSino Biological Co., Ltd. Recent Developments/Updates

Table 105. Hualan Biological Vaccine Co., Ltd. Company Information

Table 106. Hualan Biological Vaccine Co., Ltd. Description and Business Overview

Table 107. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 109. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates

Table 110. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information

Table 111. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Description and Business Overview

Table 112. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product

Table 114. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Quadrivalent Meningococcal Vaccine Distributors List

Table 118. Quadrivalent Meningococcal Vaccine Customers List

Table 119. Quadrivalent Meningococcal Vaccine Market Trends

Table 120. Quadrivalent Meningococcal Vaccine Market Drivers

Table 121. Quadrivalent Meningococcal Vaccine Market Challenges

Table 122. Quadrivalent Meningococcal Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine

Figure 2. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Quadrivalent Meningococcal Vaccine Market Share by Type: 2024 & 2031

Figure 4. Polysaccharide Vaccine Product Picture

Figure 5. Conjugate Vaccine Product Picture

Figure 6. Global Quadrivalent Meningococcal Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Quadrivalent Meningococcal Vaccine Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Quadrivalent Meningococcal Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Quadrivalent Meningococcal Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Quadrivalent Meningococcal Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global Quadrivalent Meningococcal Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. Quadrivalent Meningococcal Vaccine Report Years Considered

Figure 15. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players: Market Share by Revenue in Quadrivalent Meningococcal Vaccine in 2024

Figure 18. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Quadrivalent Meningococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Colombia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2031)

Figure 52. Global Revenue Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2031)

Figure 53. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Quadrivalent Meningococcal Vaccine by Application (2020-2031)

Figure 55. Global Revenue Market Share of Quadrivalent Meningococcal Vaccine by Application (2020-2031)

Figure 56. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 57. Quadrivalent Meningococcal Vaccine Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions